Efficacy and safety of 6.25 mg t.i.d. feverfew CO2-extract (MIG-99) in migraine prevention--a randomized, double-blind, multicentre, placebo-controlled study. (Q55041322)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Efficacy and safety of 6.25 mg t.i.d. feverfew CO2-extract (MIG-99) in migraine prevention--a randomized, double-blind, multicentre, placebo-controlled study.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/16232154

Efficacy and safety of 6.25 mg t.i.d. feverfew CO2-extract (MIG-99) in migraine prevention--a randomized, double-blind, multicentre, placebo-controlled study. (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/16232154

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Hans-Christoph Diener

1

object named as

Diener HC

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

author name string

Pfaffenrath V

2

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/16232154

Schnitker J

3

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/16232154

Friede M

4

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/16232154

Henneicke-von Zepelin HH

5

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/16232154

language of work or name

0 references

publication date

1 November 2005

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/16232154

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/16232154

25

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/16232154

11

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/16232154

1031-1041

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/16232154

Gibt es Evidenz für die Wirksamkeit komplementärmedizinischer Therapien für die Migräneprophylaxe?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2005.00950.X

21 January 2018

Herbal medicines in migraine prevention Randomized double-blind placebo-controlled crossover trial of a feverfew preparation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2005.00950.X

21 January 2018

Advances in pharmacological treatment of migraine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2005.00950.X

21 January 2018

Migraine--current understanding and treatment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2005.00950.X

21 January 2018

Adaptive sample size calculations in group sequential trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2005.00950.X

21 January 2018

Propranolol in the management of recurrent migraine: a meta-analytic review.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2005.00950.X

21 January 2018

Divalproex sodium in headache: literature review and clinical guidelines

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2005.00950.X

21 January 2018

Topiramate for migraine prevention: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2005.00950.X

21 January 2018

Migraine: preventive treatment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2005.00950.X

21 January 2018

Topiramate in migraine prevention: results of a large controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2005.00950.X

21 January 2018

Alternative therapies in headache. Is there a role?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2005.00950.X

21 January 2018

Do monoterpenes released from feverfew (Tanacetum parthenium) plants cause airborne Compositae dermatitis?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2005.00950.X

21 January 2018

Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2005.00950.X

21 January 2018

Propranolol for migraine prophylaxis

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD003225.PUB2

Identifiers

10.1111/J.1468-2982.2005.00950.X

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/16232154

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/16232154

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q55041322&oldid=2216951638"